SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-020473
Filing Date
2020-02-14
Accepted
2020-02-13 21:32:24
Documents
82
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm205325d1_10q.htm 10-Q 849425
2 EXHIBIT 31.1 tm205325d1_31-1.htm EX-31.1 10162
3 EXHIBIT 31.2 tm205325d1_31-2.htm EX-31.2 10297
4 EXHIBIT 32.1 tm205325d1_32-1.htm EX-32.1 5427
5 EXHIBIT 32.2 tm205325d1_32-2.htm EX-32.2 5253
  Complete submission text file 0001104659-20-020473.txt   9340885

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ibio-20191231.xml EX-101.INS 2724220
7 XBRL TAXONOMY EXTENSION SCHEMA ibio-20191231.xsd EX-101.SCH 65583
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ibio-20191231_cal.xml EX-101.CAL 49592
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ibio-20191231_def.xml EX-101.DEF 276327
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibio-20191231_lab.xml EX-101.LAB 458847
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibio-20191231_pre.xml EX-101.PRE 469567
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 20613399
SIC: 2834 Pharmaceutical Preparations